AllSci News
Icahn School of Medicine at Mount Sinai picks up NIH funding for mRNA-lipid nanoparticle rotator cuff therapy
Icahn School of Medicine at Mount Sinai has received a USD 2.06 million NIH R01 grant to develop an mRNA-lipid nanoparticle therapy targeting muscle...
Sur180 Therapeutics gets NIH SBIR grant to advance CRH antagonist for endometriosis
Sur180 Therapeutics receives USD 1.14 million NIH SBIR grant to advance CRH antagonist for endometriosis
University of Georgia backed with USD 1.47m NIA award for engineered bacterial Alzheimer's therapeutic
The University of Georgia has received a USD 1.47 million National Institute on Aging U01 continuation award to advance preclinical development of a...
FDA puts Atavistik’s AKT1 inhibitor on Fast Track for rare hematology disease
Cambridge, Massachusetts-based Atavistik Bio announced that the US FDA has cleared its investigational new drug (IND) application for ATV-1601 and granted the…
Matisse Pharma’s histone-neutralizing polyanion takes FDA Fast Track designation for sepsis
Netherlands-based Matisse Pharmaceuticals B.V. announced receipt of US FDA Fast Track Designation for isupartob sodium, a histone-neutralizing synthetic polyanion, for the treatment…
Cellectis’ allogeneic CD22 CAR-T receives RMAT designation for B-ALL
France-based Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS) announced that the US FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to lasmecabtagene…
Sanofi cuts off riliprubart's Phase III in CIDP after lack of efficacy
Sanofi (Euronext: SAN; Nasdaq: SNY) announced the termination of its MOBILIZE Phase III trial of riliprubart (SAR445088, BIVV020) in CIDP patients...
UCSF backed with NIA grant to explore IL-6 signaling, olamkicept in Alzheimer's
The University of California, San Francisco has received a USD 1.07 million National Institute on Aging R01 award to investigate whether IL-6...
Corvus invests USD 5m in Angel Pharma for soquelitinib development in China
Corvus Pharmaceuticals (Nasdaq: CRVS) has announced a USD 5 million investment in Angel Pharmaceuticals Ltd., its China-based development partner, as part...
Parabilis raises biotech IPO bar after upsizing to USD 670m take home
Parabilis Medicines Inc (Nasdaq: PBLS), a clinical-stage company whose lead asset is the first reported direct inhibitor of the β-catenin:TCF interaction,...
SK bioscience licenses rotavirus vaccine tech from US CDC
South Korea-based SK bioscience (KRX: 302440) has licensed injectable inactivated rotavirus vaccine technology from the US Centers for Disease Control and...
XtalPi partners with undisclosed biopharma on USD 400m oral GPCR metabolic disease program
XtalPi Holdings (HKEX: 02228) has announced a partnership worth over USD 400 million with an undisclosed international biopharma company to develop oral...
AbVacc receives USD 1m NIH award for Marburg antibody cocktail advancement
NIH backs Marburg antibody cocktail in continued SBIR support for AbVacc
ADA: Lilly's Foundayo outperforms Ozempic and Farxiga in three Phase III type 2 diabetes trials
Eli Lilly and Company (NYSE: LLY) reported Phase III data from three ACHIEVE program trials showing that orforglipron (Foundayo), its once-daily oral GLP-1...
Verge Labs to give AI platform boost to Tenacia's CNS programs
San Francisco-based Verge Labs has announced a platform collaboration with China-based Tenacia Biotechnology to apply its human tissue AI platform to select...
The AllSci Brief
Systematic R&D and deal news. Daily.